Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by somweyungguyon Oct 05, 2016 4:42pm

92 Views

Post# 25313842

Hand breaded wings or "hand picked patients"?...

Interesting to me why over 400 patients were eligible but NOT randomized..WHY?

So these people were hanging by a thread and couldn't get consent?

WHY NOT?

Did they drive themselves to the ICU?

Was the concept of running their relatives blood through a COMPLETELY SAFE filter that has been used on over 180,000 people a real concern for an unconscious patient?

Looking back to the MEDIC trial, we ( our company ) know exactly what they are looking at / dealing with...WHY did so many not get randomised? The "long drive through the night theory" holds as much water as my right ankle

Sqr

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property